Prior studies reported that those with AD have elevated plasma phosphorylated tau (pTau181 or pTau217), reduced Aβ42/Aβ40 ratios, increased NfL, and increased GFAP.45, 46, 47, 48, 49, 50, 51. Here, MAPT is linked to Alzheimer disease.